Association of peripheral lymphadenopathy with anti-Ro and anti-La antibodies in a family with systemic lupus erythematosus

Scandinavian Journal of Rheumatology

Volumn 32, Issue 1, 2003, Pages 52-54

  Bukiej, Aleksandra ^a   Undas, Anetta ^a,b   Pituch Noworolska, Anna ^a   Chmielewska, Anna ^a   Dyczek, Andrzej ^a   Musiał, Jacek ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Anti La (SSB) antibodies; Anti Ro (SSA) antibodies; Familial systemic lupus erythematosus; Lymphadenopathy

Indexed keywords

ANTIBODY; DNA ANTIBODY; HLA B8 ANTIGEN; HLA DR2 ANTIGEN; HLA DR3 ANTIGEN; LA ANTIBODY; RO ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ANTIGEN EXPRESSION; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; FAMILIAL DISEASE; FAMILY LIFE; FEMALE; HUMAN; LYMPHADENOPATHY; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIBODIES, ANTINUCLEAR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HISTOCOMPATIBILITY TESTING; HLA-B8 ANTIGEN; HLA-DR3 ANTIGEN; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPH NODES; LYMPHATIC DISEASES; MIDDLE AGED; MOTHERS; NUCLEAR FAMILY; PEDIGREE;

EID: 0037258598     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.1080/03009740310000418     Document Type: Article

References (11)

1. Scherak O, Kolarz G, Mayr WR. HLA-B8 in caucasian patients with systemic lupus erythematosus. Scand J Rheumatol 1978;7:3-6.
2. Hassan AB, Lundberg IE, Isenberg D, Wahren-Herlenius M. Serial analysis of Ro/SSA and La/SSB antibody levels and correlation with clinical disease activity in patients with systemic lupus erythematosus. Scand J Rheumatol 2002;31:133-9.
3. Catherine L, Keech BSc., McCluskey J, Gordon TP. SS-B(La) autoantibodies. In: JB Peter, Z Schoenfeld, eds. Autoantibodies. Elsevier Science B.V, 1996:789-97.
4. Wasicek CA, Reichlin M. Clinical and serological differences between systemic lupus erythematosus patients with antibodies to Ro versus patients with antibodies to Ro and La. J Clin Invest 1982;69:835-43.
5. Alexander EL, Arnett FC, Provost TT, Stevens MB. Sjögren's syndrome: association of anti-Ro (SS-A) antibodies with vasculitis, hematologic abnormalities and serologic hyperreactivity. Ann Intern Med 1983;98:155-9.
6. Kitsanou M, Andreopoulou E, Bai MK, Elisaf M, Drosos AA. Extensive lymphadenopathy as the first clinical manifestation in systemic lupus erythematosus. Lupus 2000;9:140-3.
7. Shapira Y, Weinberger A, Wysenbeek AJ. Lymphadenopathy in systemic lupus erythematosus. Prevalence and relation to disease manifestations. Clin Rheumatol 1996;15:335-8.
8. Masaru I, Hiroshi U, Tamotsu Y, Yoshinori K. Possible association of shrinking lung and anti-Ro/SSA antibody. Arthritis Rheum 2000;43:2613 (letter).
9. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF. The 1982 revised criteria for classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
10. Lopez-Logo FJ, Rodrigez-Mahou M, Escalona M, Perez T, Monteagudo I, Sanchez-Atrio A et al. Heterogeneity of the anti-Ro (SSA) response in rheumatic diseases. J Rheumatol 1994;21:1450-6.
11. Kojima M, Nakamura S, Morishita Y, Itoh H, Yoshida K, Ohno Y et al. Reactive follicular hyperplasia in the lymph node lesions from systemic lupus erythematosus patients: a clinicopathological and immunohistopathological study of 21 cases. Pathol Int 2000;50:304-12.